Related Experiment Video
Updated: Jul 11, 2026

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease
Published on: October 4, 2021
Early hospital experience with fluphenazine decanoate
1Larue D. Carter Memorial Hospital, Department of Psychiatry, Indiana University School of Medicine, Indianapolis 46202, USA.
Abstract:
Naturalistic data are reported concerning the first year of hospital use of fluphenazine decanoate. Observations revealed that staff psychiatrists were cautious in their initial use of this product, consistently reserving it for those patients who were very uncooperative about taking oral medications. Outcome of treatment was regarded as satisfactory in only 38% of the patients and a number of unusually severe and prolonged side effects were encountered. A conservative position about the use of depot medications in the treatment of schizophrenia is advocated until further studies of specific target areas for such treatment can be accomplished.
Related Concept Videos
Drug Dosing: Infants and Children
Antipsychotic Drugs: Typical and Atypical Agents
Drug Dosing: Geriatric Patients
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Antipsychotic Drugs: Therapeutic Uses and Side Effects
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
